Inj., aristada initio, 1 mg
Products billed under this code include Aristada Initio.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Aristada Initio.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Aristada Initio | Alkermes, Inc. | 65757-0500-03 | 675 | $2,334.825 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $3.459 | −$0.002 | 1 MG | Inj., aristada initio, 1 mg | v1, posted September 17, 2026 |
| 3Q26 | $3.461 | +$0.21 | 1 MG | Inj., aristada initio, 1 mg | v1, posted September 15, 2026 |
| 2Q26 | $3.251 | +$0.006 | 1 MG | Inj., aristada initio, 1 mg | v1, posted September 15, 2026 |
| 1Q26 | $3.245 | $0.00 | 1 MG | Inj., aristada initio, 1 mg | v1, posted September 15, 2026 |
| 4Q25 | $3.245 | −$0.01 | 1 MG | Inj., aristada initio, 1 mg | v1, posted September 8, 2026 |
| 3Q25 | $3.255 | +$0.112 | 1 MG | Inj., aristada initio, 1 mg | v1, posted March 10, 2026 |
| 2Q25 | $3.143 | +$0.012 | 1 MG | Inj., aristada initio, 1 mg | v1, posted March 10, 2026 |
| 1Q25 | $3.131 | −$0.06 | 1 MG | Inj., aristada initio, 1 mg | v1, posted December 19, 2025 |
| 4Q24 | $3.191 | +$0.047 | 1 MG | Inj., aristada initio, 1 mg | v1, posted June 11, 2025 |
| 3Q24 | $3.144 | +$0.062 | 1 MG | Inj., aristada initio, 1 mg | v1, posted June 11, 2025 |
| 2Q24 | $3.082 | −$0.009 | 1 MG | Inj., aristada initio, 1 mg | v1, posted March 11, 2025 |
| 1Q24 | $3.091 | +$0.038 | 1 MG | Inj., aristada initio, 1 mg | v1, posted December 19, 2024 |
| 4Q23 | $3.053 | −$0.007 | 1 MG | Inj., aristada initio, 1 mg | v1, posted October 10, 2024 |
| 3Q23 | $3.06 | +$0.106 | 1 MG | Inj., aristada initio, 1 mg | v1, posted June 5, 2024 |
| 2Q23 | $2.954 | −$0.02 | 1 MG | Inj., aristada initio, 1 mg | v1, posted February 23, 2024 |
| 1Q23 | $2.974 | −$0.008 | 1 MG | Inj., aristada initio, 1 mg | v1, posted December 6, 2023 |
| 4Q22 | $2.982 | +$0.041 | 1 MG | Inj., aristada initio, 1 mg | v1, posted June 22, 2023 |
| 3Q22 | $2.941 | −$0.046 | 1 MG | Inj., aristada initio, 1 mg | v1, posted June 9, 2023 |
| 2Q22 | $2.987 | −$0.016 | 1 MG | Inj., aristada initio, 1 mg | v1, posted December 14, 2022 |
| 1Q22 | $3.003 | −$0.047 | 1 MG | Inj., aristada initio, 1 mg | v1, posted June 8, 2022 |
| 4Q21 | $3.05 | +$0.122 | 1 MG | Inj., aristada initio, 1 mg | v1, posted June 2, 2022 |
| 3Q21 | $2.928 | +$0.018 | 1 MG | Inj., aristada initio, 1 mg | v1, posted June 2, 2022 |
| 2Q21 | $2.91 | $0.00 | 1 MG | Inj., aristada initio, 1 mg | v1, posted March 1, 2022 |
| 1Q21 | $2.91 | – | 1 MG | Inj., aristada initio, 1 mg | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.